For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

Johnson & Johnson said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of ...

Yoga can significantly reduce urinary incontinence by strengthening pelvic floor muscles. It's a low-risk, accessible ...

UChicago Medicine has become the first medical center in Illinois to implant the Revi neuromodulation device, an exciting new ...

Bladder infections, also known as urinary tract infections (UTIs), are common medical conditions that affect millions of ...

Self-care with overactive bladder involves making lifestyle changes, taking medications, going to physical therapy, and ...

Cathy Lee Mendelsohn, PhD A new study in mice by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has ...

Neurogenic bladder is when a problem in your brain, spinal cord, or central nervous system makes you lose control of your bladder. You may pee too much or too little. You could have symptoms of ...

TORONTO, ON / ACCESSWIRE / October 7, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and ...

A recent study published in the New England Journal of Medicine and found no significant survival benefit of extended ...

We randomly assigned, in a 1:1 ratio, patients with localized muscle-invasive bladder cancer of clinical ... protocol-specified quality-control assessment involving 100 randomly selected patients ...

The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher ...